|
Back to Home » January 2018 News » Nuevolution to Receive License Fee Payment of USD 750,000 |
Nuevolution to Receive License Fee Payment of USD 750,000 |
January 04, 2018
STOCKHOLM, Jan. 4, 2018 /PRNewswire/ -- Nuevolution AB (publ) (NUE.ST) today announced that Janssen Biotech, one of the Pharmaceutical Companies of Johnson & Johnson, has exercised its option to license one of the research programs under the multi-target collaboration entered between...
Source URL: https://www.prnewswire.com/news-releases/nuevolution-to-receive-license-fee-payment-of-usd-750000-300577473.html
|
|
|
|
